Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Helvetic BioPharma

www.helveticbio.com

Latest From Helvetic BioPharma

BiocurePharm Looks Beyond North America Via Canada IPO

With a business model that sets it apart from other South Korean bioventures, BiocurePharm plans to set up manufacturing facilities in North America and worldwide with local partners, and is launching a Canadian IPO in a bid to transform into a truly multinational operation, its CEO says.

Biosimilars Financing

BiocurePharm Looks Beyond North America Via Canada IPO

With a business model that sets it apart from other South Korean bioventures, BiocurePharm plans to set up manufacturing facilities in North America and worldwide with local partners, and is launching a Canadian IPO in a bid to transform into a truly multinational operation, its CEO says.

Biosimilars Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Helvetic BioPharma
  • Senior Management
  • Mohsen Nayebpour, CEO
  • Contact Info
  • Helvetic BioPharma
    Phone: 91 922 0660
    Via Nassa 19
    Lugano, 6900
    Switzerland
Advertisement
Advertisement
UsernamePublicRestriction

Register